These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38639925)

  • 21. Extracellular vesicle-encapsulated microRNA-425-derived from drug-resistant cells promotes non-small-cell lung cancer progression through DAPK1-medicated PI3K/AKT pathway.
    Guo Z; Ye H; Zheng X; Yin W; He J
    J Cell Physiol; 2021 May; 236(5):3808-3820. PubMed ID: 33258116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.
    Zhu WY; Luo B; An JY; He JY; Chen DD; Xu LY; Huang YY; Liu XG; Le HB; Zhang YK
    Cancer Invest; 2014 Oct; 32(8):394-401. PubMed ID: 24945821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
    Dong X; Chang M; Song X; Ding S; Xie L; Song X
    Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinesin family member 3C (KIF3C) is a novel non-small cell lung cancer (NSCLC) oncogene whose expression is modulated by microRNA-150-5p (miR-150-5p) and microRNA-186-3p (miR-186-3p).
    Liu H; Liu R; Hao M; Zhao X; Li C
    Bioengineered; 2021 Dec; 12(1):3077-3088. PubMed ID: 34193018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.
    Liang G; Meng W; Huang X; Zhu W; Yin C; Wang C; Fassan M; Yu Y; Kudo M; Xiao S; Zhao C; Zou P; Wang Y; Li X; Croce CM; Cui R
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4347-4357. PubMed ID: 32041891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.
    Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M
    Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
    Mao M; Wu Z; Chen J
    Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
    Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
    Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments.
    Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human umbilical vein endothelial cells-derived microRNA-203-containing extracellular vesicles alleviate non-small-cell lung cancer progression through modulating the DTL/p21 axis.
    Ma T; Hu Y; Guo Y; Zhang Q
    Cancer Gene Ther; 2022 Jan; 29(1):87-100. PubMed ID: 33558703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer.
    Yuwen DL; Sheng BB; Liu J; Wenyu W; Shu YQ
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2650-2658. PubMed ID: 28678319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
    Wei T; Cheng S; Fu XN; Feng LJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S; Qin H; Liu K; Wang H; Bai S; Liu S; Shao Z; Zhang Y; Song B; Xu X; Shen J; Zeng P; Shi X; Chen H; Gao S; Xu J; Pan Y; Xiong L; Li F; Zhang D; Jiao X; Jin G
    Clin Transl Med; 2021 Sep; 11(9):e520. PubMed ID: 34586739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA AL139294.1 can be transported by extracellular vesicles to promote the oncogenic behaviour of recipient cells through activation of the Wnt and NF-κB2 pathways in non-small-cell lung cancer.
    Ma X; Chen Z; Chen W; Chen Z; Shang Y; Zhao Y; Li L; Zhou C; He J; Meng X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):20. PubMed ID: 38229152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-374a-5p inhibits non-small cell lung cancer cell proliferation and migration via targeting NCK1.
    Guo Q; Wang H; Xu Y; Wang M; Tian Z
    Exp Ther Med; 2021 Sep; 22(3):943. PubMed ID: 34306207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.
    Wei K; Pan C; Yao G; Liu B; Ma T; Xia Y; Jiang W; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 44(4):1545-1558. PubMed ID: 29197876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A
    Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
    Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
    Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
    Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
    Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.